Medical NewsCDSCO Panel Accepts Glenmark’s Apremilast Trial Report, Seeks 2-Year PSUR Data DRRA3 hours ago01 mins CDSCO Panel Accepts Glenmark’s Apremilast Trial Report, Seeks 2-Year PSUR Data We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link Post navigation Previous: Sun Pharma Gets CDSCO Panel Nod For Alfuzosin-Tadalafil FDC Post-Marketing StudyNext: Tripura Govt Issues New Guidelines Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
NBE notifies on joining report, Self-Appraisal Process at OPJR- Complete details here DRRA1 hour ago 0